EDGAR Filing Documents for 0001654954-16-002634

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]

SEC Accession No. 0001654954-16-002634

Filing Date

2016-10-05

Accepted

2016-10-04 18:31:49

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	AMENDMENT NO. 6 TO FORM S-1	azurrxs1a-am6_sep2016.htm	S-1/A	2082585
2	UNDERWRITING AGREEMENT	ex1-1.htm	EX-1.1	320537
3	OPINION	ex5-1.htm	EX-5.1	9177
4	CONSENT	ex23-1.htm	EX-23.1	3425
5	IMAGE	azurrx_logo.jpg	GRAPHIC	17637
6	IMAGE	loebimage.jpg	GRAPHIC	14048
	Complete submission text file	0001654954-16-002634.txt		2460695

Mailing Address 760 PARKSIDE AVENUE SUITE 217 BROOKLYN NY 11226

Business Address 760 PARKSIDE AVENUE SUITE 217 BROOKLYN NY 11226 646-699-7855

AzurRx BioPharma, Inc. (Filer) CIK: 0001604191 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: S-1/A | Act: 33 | File No.: 333-212511 | Film No.: 161920685
SIC: 2834 Pharmaceutical Preparations